Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001247452 | SCV001420875 | benign | Nemaline myopathy 2 | 2024-01-09 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001550132 | SCV001770418 | uncertain significance | not provided | 2020-06-04 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Breakthrough Genomics, |
RCV001550132 | SCV005187931 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001247452 | SCV002083951 | uncertain significance | Nemaline myopathy 2 | 2020-01-17 | no assertion criteria provided | clinical testing |